Alexandra Paul, MD
Neurosurgery · Albany, NYNPI 1154659506
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (46.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Microvention, Inc. accounts for 75.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $74,904, more than ten times the $165 reported in 2019.
Across 130 payments — averaging $694.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microvention, Inc.$68K
- Penumbra, Inc.$12K
- Medtronic$4K
- Chiesi USA, Inc.$4K
- Irras USA, Inc.$933
- Johnson & Johnson$616
- plus $494 from 4 others
Across 28 payments — averaging $9301.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Microvention, Inc.$260K
What the payments were for
- Consulting fees$20,40123%
- Speaking & faculty fees$42,15047%
- Travel & lodging$22,48725%
- Food & beverage$5,2576%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microvention, Inc. | 64 | $68,013 |
| Penumbra, Inc. | 11 | $12,106 |
| Medtronic(2 entities) | 32 | $4,258 |
| Chiesi USA, Inc. | 1 | $3,875 |
| Irras USA, Inc. | 2 | $933 |
| Johnson & Johnson | 8 | $616 |
| Exactech, Inc. | 2 | $260 |
| Imperative Care, Inc | 7 | $159 |
| Boston Scientific | 2 | $56 |
| Tricoast Surgical Solutions LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB Aneurysm Embolization System$37,889
- Penumbra System$11,550
- STENT$8,216
- SOFIA EX 5F - 105CM STR$4,340
- KENGREAL$3,875
- Pipeline$3,520
- SOFIA 6F-131CM STR$640
- Azur CX Detachable$484
- ERIC RETRIEVAL DEVICE$484
- NA$253
- Penumbra Coil 400$167
- Benchmark$164
- VA-LCP$140
- VANTAGE$140
- RED 72$129
- WEB$123
- EQUINOXE$120
How this compares
Too few neurosurgery providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 11 | $106 |
Paid to pharmacies, not to this prescriber.
Other neurosurgery in Albany
- David AltschulBronx$440K
- Benjamin CohenRockville Centre$19K
- Joshua BedersonNew York$12K
- Tanvir ChoudhriNew York$4K
- Ning LinNew York$4K
- Isabelle GermanoNew York$4K
- William SonsteinRockville Centre$4K
- Ori BarzilaiNew York$3K
- Michael HahnKingston$2K
- Caitlin HoffmanNew York$510
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.